E(zip)31-631-6, Rho112-6/Rho1[+] has visible phenotype
Rho112-6/Rho1[+], RhoGEF211-3 has visible | dominant phenotype
Rho112-6/Rho1[+], RhoGEF24.1 has visible phenotype
Rho112-6, zip[+]/zipEbr has partially lethal phenotype
E(zip)18-5[+]/E(zip)18-518-5, Rho112-6 has visible | dominant phenotype
E(zip)31-631-6/E(zip)31-6[+], Rho112-6 has visible | dominant phenotype
Rho112-6, RhoGEF24.1/RhoGEF2[+] has visible | dominant phenotype
E(zip)12-5[+]/E(zip)12-512-5, Rho112-6 has visible phenotype
Rho112-6, RhoGEF211-3/RhoGEF2[+] has visible phenotype
E(zip)12-512-5, Rho112-6/Rho1[+] has visible | dominant phenotype
E(zip)18-518-5, Rho112-6/Rho1[+] has visible phenotype
E(zip)31-631-6, Rho112-6 has leg phenotype
Rho112-6/Rho1[+], RhoGEF211-3 has leg phenotype
E(zip)18-5[+]/E(zip)18-518-5, Rho112-6 has leg phenotype
Rho112-6, RhoGEF24.1 has leg phenotype
E(zip)31-631-6/E(zip)31-6[+], Rho112-6 has leg phenotype
Rho112-6, RhoGEF24.1/RhoGEF2[+] has leg phenotype
E(zip)12-512-5, Rho112-6 has leg phenotype
Rho112-6, RhoGEF211-3 has leg phenotype
E(zip)12-512-5, Rho112-6/Rho1[+] has leg phenotype
E(zip)18-518-5, Rho112-6 has leg phenotype
Rho112-6 shows a strong interaction (at least 50% of double heterozygotes have at least one malformed leg) with the following mutations: RhoGEF211-3, zipEbr, Sb63b and Sb70. Rho112-6 shows a moderate interaction (25-49% of double heterozygotes have at least one malformed leg) with the following mutations: E(zip)18-518-5, E(zip)31-631-6, RhoGEF24.1 and E(zip)12-512-5. Rho112-6 shows a weak interaction (5-24% of double heterozygotes have at least one malformed leg) with the following mutations: rok1, rok2 and Df(2R)Jp1. br1 fails to show a significant genetic interaction (assayed in terms of a malformed leg phenotype) with Rho112-6. Rho112-6 shows a strong interaction (at least 50% of double heterozygotes have at least one malformed wing) with the following mutations: zipEbr, Sb63b and Sb70. Sbsbd-201/Sbsbd-1 shows a strong interaction (at least 50% of double mutants have at least one malformed leg) with the following mutations: Rho112-6/+.